In addition to evaluating levosimendan in the Phase 3 LEVO-CTS trial for low cardiac output syndrome (LCOS) in cardiac surgery, Tenax Therapeutics, Inc. (TENX) is collaborating with the Imperial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback